-
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
Tuesday, March 12, 2013 - 1:19pm | 820Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of February. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx...
-
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
Thursday, February 28, 2013 - 4:13pm | 841Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Illumina (NASDAQ: ILMN) and Vertex Pharmaceuticals (NASDAQ: VRTX) grew somewhat between the January 31...
-
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
Tuesday, February 12, 2013 - 2:29pm | 829Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the latter two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Vertex Pharmaceuticals (NASDAQ: VRTX) and VIVUS...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Saturday, January 26, 2013 - 1:17pm | 836Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx Pharmaceuticals (NASDAQ: ONXX) and Vertex...
-
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Friday, December 28, 2012 - 12:10pm | 823Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of December. The number of shares sold short in Amgen (NASDAQ: AMGN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN) and Illumina (NASDAQ: ILMN) grew somewhat between the...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Wednesday, December 12, 2012 - 1:57pm | 828Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of November. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Illumina (NASDAQ: ILMN) and Regeneron Pharmaceuticals (NASDAQ: REGN) grew somewhat between the November 15 and...
-
Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)
Monday, November 12, 2012 - 2:24pm | 844Read More...The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of October. Shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN) and VIVUS (NASDAQ: VVUS) grew somewhat between...
-
Barron's Recap: The 25 Best Dividend Funds
Sunday, November 4, 2012 - 3:09pm | 820Read More...This weekend in Barron's online: the top dividend funds, investing in Brazil, the prospects for Bank of New York Mellon, Radian Group and Callaway Golf, as well as the momentum favors Romney. Cover Story "Top Dividend Funds" by Steve Garmhausen. Over the past few years, the search for income and...
-
Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)
Thursday, October 25, 2012 - 2:09pm | 847Read More...The short interest in biotech and emerging pharmaceutical companies was mixed in the first two weeks of October. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG), Dendreon (NASDAQ: DNDN), Illumina (NASDAQ: ILMN), Onyx Pharmaceuticals (NASDAQ...
-
Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)
Monday, October 15, 2012 - 6:59am | 826Read More...After largely rising in the previous period, short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of September. Shares sold short in Amgen (NASDAQ: AMGN), Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Illumina (NASDAQ: ILMN), Onyx...
-
Short Sellers Shy Away from Biotech Firms
Thursday, September 13, 2012 - 1:34pm | 575Read More...The short interest data is out from the August 31 settlement date. By and large short sellers have retreated from gambles on biotech firms, compared to the August 15 settlement date. A few notable exceptions were Amgen (NASDAQ: AMGN), for which short interest was higher by 8.8 percent to 12.8...
-
Short Sellers Shy Away from Biotech Firms
Monday, August 13, 2012 - 6:18am | 547Read More...The short interest data is out from the July 31 settlement date. By and large short sellers have retreated from gambles on biotech firms compared to the July 13 settlement date. A couple of notable exceptions were Dendreon (NASDAQ: DNDN), for which short interest was higher by 7 percent to 40.8...
-
Fifteen Health Care ETFs Trading Near 52-Week Highs
Thursday, July 21, 2011 - 1:57pm | 1271Read More...iShares Dow Jones US Healthcare Provider (NYSE: IHF) is up more than 19% year to date. The fund invests at least 90% of its assets in securities of the underlying index, which measures the performance of the health care providers sector of the U.S. equity market. Top holdings include UnitedHealth...
-
Twelve Health Care ETFs Trading Near 52-Week Highs
Wednesday, July 13, 2011 - 7:38am | 987Read More...PowerShares S&P SmallCap Health Care (NYSE: PSCH) is up nearly 22% year to date. The investment seeks to replicate the S&P SmallCap 600 Capped Health Care index, which is comprised of common stocks of U.S. health care companies. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN...
-
Jefferies Maintains Buy on Celgene
Wednesday, June 22, 2011 - 9:33am | 95Read More...Jefferies is out with its report today on Celgene (NASDAQ: CELG), maintaining Buy. In a note to clients, Jefferies writes, "The FDA released draft guidance for non-small cell lung cancer, recommending overall survival as the standard endpoint for efficacy, as expected, but leaving the possibility...
